Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The American Journal of Clinical Nutrition, 106 (6), 1514-1528
Does Semaglutide Reduce Visceral Fat or Just Weight Loss
Retatrutide for managing overweight and obesity [ID6644]
A 2025 systematic review and meta-analysis in Reviews in Endocrine and Metabolic Disorders found that tirzepatide (the active ingredient in Mounjaro and Zepbound) reduced hsCRP by approximately 33% and IL-6 by approximately 18% compared to placebo across patients with and without diabetes. A growing body of research suggests this effect occurs through direct action on the NF-B pathway, a master switch of inflammation
Medical supervision is essential to minimize side effects and ensure safe treatment
Phase 3 trial completion timeline Seven Phase 3 trials are expected to report results during this year
US$ 27.73
US$ 20.56
US$ 29.00
US$ 23.60
US$ 27.67
